Mediphage Bioceuticals, a preclinical-stage biotechnology company, is developing a next-generation non-viral gene therapy platform based on its proprietary ministring DNA (msDNA) technology. A Toronto-based company Mediphage uses a proprietary manufacturing process to develop safe and redosable gene delivery vectors. msDNA is designed to overcome critical challenges facing viral gene therapies and leverage advancements in the delivery of nucleic acids.
Founded in 2016
Inaccurate data? Flag it here.
Open jobs at Mediphage
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.
We only use strictly necessary, first-party cookies on this job board. These are cookies that are necessary to deliver this service to you, or are necessary for Ontario Bioscience Innovation Organization to understand how it is being used. Read our Cookie Policy.